Skip to content

Click to Download the Agenda

April 13:

Keynote: Update on GDUFA implementation
Kathleen Uhl, MD
View Recording
GDUFA Regulatory Science Update
Wenlei Jiang, PhD
View Recording
Fundamentals of Bioequivalence
Trueman W. Sharp, MD, MPH

View Recording
How to use the Inactive Ingredient Database (IID)
Susan Zuk, MS
View Recording
How an ANDA Gets Reviewed
Kevin Denny, PharmD
Craig Kiester, RPh, MS, RAC
View Recording
Question-based Review (QbR) in an Integrated Review Approach
Damaris Maldonado, BS
View Recording
Division of Microbiology Assessment: Who we are, what we do and our recommendations to industry
Lynne Ensor, PhD

Pre-Approval Inspections
Robert Iser, MS

View Lynn Ensor Recording

View Robert Iser and Joint Q&A Recording

April 14:

Overview of Controlled Correspondence Process Controlled Correspondence
Marissa McNall, PharmD

Content and Format for Accurate Submissions
Thomas Hinchliffe, PharmD

View McNall Recording

View Hinchliffe and Joint Q&A Recording

ANDA Submissions – Refuse-to-Receive and eCTD considerations
Johnny Young, MA
Julia Lee, PharmD
View Recording
Current Trends in Labeling and Best Practices
Lillie Golson, PharmD
View Recording
Entering the Home Stretch: GDUFA I Entering its Final Year
Donal Parks, MBA, MPM
View Recording
Common errors and opportunities to improve FDA submissions and communications
Giuseppe Randazzo, MS
Lieutenant Geoffrey Wu
View Recording